Plain-English translation of NCT07794150 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
India
Phase
Safety & dosing
Sponsor
Corium Innovations, Inc.
Enrollment target
~250 participants
Started
August 2026
Primary completion
May 2027
Age range
40 Years – 75 Years
Sex
Female only
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ann Vollmer
Corium Innovations, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.